Ping An Biomedical Co. (PASW) Income Statement

Ping An Biomedical Co. reported revenue of $34.15M in fiscal 2025 (fiscal year ended Sep 30, 2025), down 61.0% from $87.62M a year earlier. Ping An Biomedical Co. posted a net loss of $12.83M, compared with a net loss of $1.28M a year earlier. Gross margin was 2.8% and operating margin -43.1%. In the most recent quarter, H1 fiscal 2026 (ended Mar 31, 2026), revenue was CNY 9.59M, down 47.4% from the same quarter a year earlier.

Ping An Biomedical Co. Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Ping An Biomedical Co., Ltd. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period ending	Sep 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Revenue & Gross Profit
Revenue	34.15	87.62	82.56	114.55	99.52
Cost of Revenue	33.20	82.21	78.32	100.40	85.25
Gross Profit	0.95	5.42	4.24	14.14	14.27
Operating Expenses
Research & Development	0.00	0.00	0.00	0.00	0.00
Selling, General & Administrative	6.30	4.85	3.60	3.11	3.76
Operating Expenses	15.65	5.42	3.63	2.99	6.00
Operating Income	-14.70	0.00	0.61	11.15	8.27
Other Income/Expense
Interest Income	0.33	0.00	0.16	0.04	0.00
Interest Expense	0.31	0.71	1.74	1.57	-1.36
Other Income/Expense	0.00	0.02	1.01	0.00	-0.45
Income
Income Before Tax	-14.68	-0.68	0.04	9.63	7.82
Income Tax Expense	-1.86	0.60	1.04	2.40	2.61
Net Income	-12.83	-1.28	-0.99	7.23	5.21
Net Income - Continuous Operations	-12.83	-1.28	-0.99	7.23	5.21
Net Income - Discontinued Operations	-	-	-	-	-
EBITDA	-14.37	0.47	1.81	11.61	8.29
EBIT	-14.38	0.02	1.78	11.19	8.27
Depreciation & Amortization	0.01	0.45	0.42	0.41	0.02
Earnings Per Share
Basic EPS	-	-3.00	-	-	12.00
Diluted EPS	-	-	-	-	-
Basic Shares Outstanding	0.00	0.45	20.50	20.50	0.45
Diluted Shares Outstanding	0.00	0.45	20.50	20.50	0.45

Source: Company financial statements from annual and quarterly filings. Data as of Mar 31, 2026. Data sources and methodology

Frequently Asked Questions About Ping An Biomedical Co. Financial Statements

What was Ping An Biomedical Co.'s revenue in fiscal 2025?

Ping An Biomedical Co. reported revenue of $34.15M in fiscal 2025 (fiscal year ended Sep 30, 2025). That was down 61.0% from $87.62M a year earlier.

Is Ping An Biomedical Co. profitable?

No. Ping An Biomedical Co. reported a net loss of $12.83M in fiscal 2025. In fiscal 2024 it lost $1.28M.

What is Ping An Biomedical Co.'s operating margin?

Ping An Biomedical Co.'s operating income was −$14.70M on revenue of $34.15M in fiscal 2025, an operating margin of -43.1%, compared with 0.00% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition